Items where authors include "Buyse, M"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Fokas, E, Appelt, A orcid.org/0000-0003-2792-9218, Glynne-Jones, R et al. (27 more authors) (2021) International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nature Reviews Clinical Oncology, 18. pp. 805-816. ISSN 1759-4774

Fokas, E, Glynne-Jones, R, Appelt, A orcid.org/0000-0003-2792-9218 et al. (13 more authors) (2020) Outcome measures in multimodal rectal cancer trials. Lancet Oncology, 21 (5). e252-e264. ISSN 1470-2045

Burzykowski, T, Coart, E, Saad, ED et al. (24 more authors) (2019) Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. JAMA Network Open, 2 (9). e1911750.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Alberro, JA, Ballester, B et al. (596 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Martin, M, Holmes, FA, Ejlertsen, B et al. (32 more authors) (2017) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology, 18 (12). pp. 1688-1700. ISSN 1470-2045

Brown, SR, Gregory, WM, Twelves, CJ et al. (5 more authors) (2011) Designing phase II trials in cancer: a systematic review and guidance. British Journal of Cancer, 105 (2). 194 - 199 . ISSN 1532-1827

This list was generated on Sat Mar 23 09:27:19 2024 GMT.